{"key":"ace-031","slug":"ace-031","name":"ACE-031","other_names":[],"kind":"single","area":{"slug":"muscle-bone","name":"Muscle and bone"},"classification":"Soluble activin receptor type IIB","standing":{"id":"human-studies","label":"Studied in people","rank":2},"summary":"A fusion protein that traps myostatin and related ligands. Trials in Duchenne muscular dystrophy were stopped early.","cas_number":null,"molecular_formula":null,"molecular_weight":null,"components":[],"has_article":false,"pubmed":{"papers":12,"in_humans":10,"clinical_trials":2},"retired":false,"updated_at":"2026-11-18T00:17:24.691Z","url":"https://pepts.wiki/compounds/ace-031","article":null,"evidence":{"query":"(\"ACE-031\"[tiab] OR ramatercept[tiab])","fetched_at":"2026-11-16T22:50:00.084Z","counts":{"rcts":2,"human":10,"total":12,"reviews":0,"clinicalTrials":2},"years":[{"year":2012,"count":1},{"year":2013,"count":1},{"year":2014,"count":0},{"year":2015,"count":0},{"year":2016,"count":2},{"year":2017,"count":1},{"year":2018,"count":0},{"year":2019,"count":0},{"year":2020,"count":0},{"year":2021,"count":0},{"year":2022,"count":1},{"year":2023,"count":1},{"year":2024,"count":0},{"year":2025,"count":2},{"year":2026,"count":1}],"top":[{"doi":"10.1002/mus.23539","url":"https://pubmed.ncbi.nlm.nih.gov/23169607/","kind":"rct","pmid":"23169607","year":2013,"title":"A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers","venue":"Muscle & nerve","authors":"Attie KM, Borgstein NG, Yang Y, et al."},{"doi":"10.1002/mus.25268","url":"https://pubmed.ncbi.nlm.nih.gov/27462804/","kind":"rct","pmid":"27462804","year":2017,"title":"Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial","venue":"Muscle & nerve","authors":"Campbell C, McMillan HJ, Mah JK, et al."},{"doi":"10.1002/dta.3898","url":"https://pubmed.ncbi.nlm.nih.gov/40312924/","kind":"study","pmid":"40312924","year":2025,"title":"Gel Electrophoretic Detection of Black Market ACE-031","venue":"Drug testing and analysis","authors":"Reichel C, Filip T, Gmeiner G, et al."},{"doi":"10.5692/clinicalneurol.51.1157","url":"https://pubmed.ncbi.nlm.nih.gov/22277518/","kind":"study","pmid":"22277518","year":2011,"title":"[Anti-myostatin antibody therapy for myopathies]","venue":"Rinsho shinkeigaku = Clinical neurology","authors":"Sunada Y"},{"doi":"10.1371/journal.pone.0273193","url":"https://pubmed.ncbi.nlm.nih.gov/36054096/","kind":"study","pmid":"36054096","year":2022,"title":"The relationship between myodural bridges, hyperplasia of the suboccipital musculature, and intracranial pressure","venue":"PloS one","authors":"Li C, Yue C, Liu ZC, et al."},{"doi":null,"url":"https://pubmed.ncbi.nlm.nih.gov/20383346/","kind":"study","pmid":"20383346","year":2010,"title":"Gateways to clinical trials","venue":"Methods and findings in experimental and clinical pharmacology","authors":"Tomillero A, Moral MA"},{"doi":"10.1038/s41598-023-45820-x","url":"https://pubmed.ncbi.nlm.nih.gov/37919345/","kind":"study","pmid":"37919345","year":2023,"title":"The relationship between myodural bridge, atrophy and hyperplasia of the suboccipital musculature, and cerebrospinal fluid dynamics","venue":"Scientific reports","authors":"Yang H, Wei XS, Gong J, et al."},{"doi":null,"url":"https://pubmed.ncbi.nlm.nih.gov/22068480/","kind":"study","pmid":"22068480","year":2011,"title":"[Myostatin blockade therapy for muscular atrophy]","venue":"Brain and nerve = Shinkei kenkyu no shinpo","authors":"Sunada Y"}]},"library_version":"183:2026-11-17T11:05:42.386Z","attribution":"Data from Pepts.wiki (https://pepts.wiki), CC BY 4.0. Link back to the compound's page.","notice":"We are not doctors, and nothing on Pepts.wiki is medical advice or a recommendation to use anything. The wiki sets out what studies measured, as clearly and evenly as it can, so you can make better-informed decisions. Always consult a medical professional before acting on anything you read here."}